Published in Breast Cancer Res Treat on June 19, 2012
The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study. Int J Radiat Oncol Biol Phys (2014) 1.61
Manual lymphatic drainage for lymphedema following breast cancer treatment. Cochrane Database Syst Rev (2015) 1.03
Impact of Ipsilateral Blood Draws, Injections, Blood Pressure Measurements, and Air Travel on the Risk of Lymphedema for Patients Treated for Breast Cancer. J Clin Oncol (2015) 0.89
Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer. Breast Cancer Res Treat (2013) 0.88
Risk of lymphedema after mastectomy: potential benefit of applying ACOSOG Z0011 protocol to mastectomy patients. Breast Cancer Res Treat (2014) 0.86
Quantitative and morphologic change associated with breast cancer-related lymphedema. Comparison of 3.0T MRI to external measures. Lymphat Res Biol (2014) 0.84
Long-term effects of complex decongestive therapy in breast cancer patients with arm lymphedema after axillary dissection. Ann Rehabil Med (2013) 0.82
Lymphedema following treatment for breast cancer: a new approach to an old problem. Crit Rev Oncol Hematol (2013) 0.81
Screening for breast cancer-related lymphedema: the need for standardization. Oncologist (2013) 0.81
Prospective surveillance of breast cancer-related lymphoedema in the first-year post-surgery: feasibility and comparison of screening measures. Support Care Cancer (2014) 0.79
Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohort. Breast Cancer Res Treat (2015) 0.78
Establishing and sustaining a prospective screening program for breast cancer-related lymphedema at the massachusetts general hospital: lessons learned. J Pers Med (2015) 0.78
The effect of stellate ganglion block on intractable lymphedema after breast cancer surgery. Korean J Pain (2015) 0.77
Side of cancer does not influence limb volumes in women prior to breast cancer surgery. Lymphat Res Biol (2014) 0.75
In reply. Oncologist (2013) 0.75
Immediate Implant Reconstruction Is Associated With a Reduced Risk of Lymphedema Compared to Mastectomy Alone: A Prospective Cohort Study. Ann Surg (2016) 0.75
Bilateral Changes in Deep Tissue Environment After Manual Lymphatic Drainage in Patients with Breast Cancer Treatment-Related Lymphedema. Lymphat Res Biol (2017) 0.75
Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol (2007) 4.05
The diagnosis and treatment of peripheral lymphedema. 2009 Concensus Document of the International Society of Lymphology. Lymphology (2009) 3.95
Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer (2008) 3.49
Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol (2008) 2.77
Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol (2006) 2.69
Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol (2010) 2.52
A comparison of four diagnostic criteria for lymphedema in a post-breast cancer population. Lymphat Res Biol (2005) 2.42
Randomized controlled trial of weight training and lymphedema in breast cancer survivors. J Clin Oncol (2006) 2.27
Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study. QJM (2005) 2.25
The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol (2009) 2.16
The problem of post-breast cancer lymphedema: impact and measurement issues. Cancer Invest (2005) 2.12
Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial. Ann Surg Oncol (2011) 1.93
Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study. Arch Surg (2010) 1.91
Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA (2010) 1.83
Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema. Cancer (2010) 1.80
Lymphedema and quality of life in survivors of early-stage breast cancer. Arch Surg (2002) 1.67
Risk of lymphedema after regional nodal irradiation with breast conservation therapy. Int J Radiat Oncol Biol Phys (2003) 1.57
Translocon closure to Ca2+ leak in proliferating vascular smooth muscle cells. Am J Physiol Heart Circ Physiol (2009) 1.52
Physical and psychological impairments of women with upper limb lymphedema following breast cancer treatment. Psychooncology (2010) 1.47
Minimal limb volume change has a significant impact on breast cancer survivors. Lymphology (2009) 1.46
Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients. Breast J (2009) 1.42
Microvascular breast reconstruction and lymph node transfer for postmastectomy lymphedema patients. Ann Surg (2012) 1.42
The grading of lymphedema in oncology clinical trials. Semin Radiat Oncol (2003) 1.32
Post-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months. Lymphology (2010) 1.30
Prognostic factors for lymphedema after primary treatment of breast carcinoma. Cancer (2001) 1.21
Current views on diagnostic approach and treatment of lymphedema. Am J Med (2012) 1.21
Standardized method for quantification of developing lymphedema in patients treated for breast cancer. Int J Radiat Oncol Biol Phys (2010) 1.21
Assessment of breast cancer-related arm lymphedema--comparison of physical measurement methods and self-report. Cancer Invest (2010) 1.20
30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA. J Lymphoedema (2009) 1.20
Breast cancer treatment, BMI, post-op swelling/lymphoedema. J Lymphoedema (2008) 1.15
Lymphedema secondary to breast cancer: how choice of measure influences diagnosis, prevalence, and identifiable risk factors. Lymphology (2008) 1.14
A review of measures of lymphedema. Cancer (1998) 1.10
Long-term management of breast cancer-related lymphedema after intensive decongestive physiotherapy. Breast Cancer Res Treat (2006) 1.06
Longitudinal change of treatment-related upper limb dysfunction and its impact on late dysfunction in breast cancer survivors: a prospective cohort study. J Surg Oncol (2010) 1.05
Time course of mild arm lymphedema after breast conservation treatment for early-stage breast cancer. Int J Radiat Oncol Biol Phys (2010) 0.99
[Lymphedema after breast carcinoma. A study of 5868 cases]. Dtsch Med Wochenschr (1997) 0.98
Different physical treatment modalities for lymphoedema developing after axillary lymph node dissection for breast cancer: a review. Eur J Obstet Gynecol Reprod Biol (2009) 0.97
Factors that affect intention to avoid strenuous arm activity after breast cancer surgery. Oncol Nurs Forum (2009) 0.97
Comparison of diagnostic accuracy of clinical measures of breast cancer-related lymphedema: area under the curve. Arch Phys Med Rehabil (2011) 0.96
Morbidity of sentinel node biopsy in breast cancer: the relationship between the number of excised lymph nodes and lymphedema. Ann Surg Oncol (2010) 0.94
Efficacy of pneumatic compression and low-level laser therapy in the treatment of postmastectomy lymphoedema: a randomized controlled trial. Clin Rehabil (2009) 0.93
Breast cancer-related lymphedema: attention to a significant problem resulting from cancer diagnosis. J Clin Oncol (2008) 0.92
Operational equivalence of bioimpedance indices and perometry for the assessment of unilateral arm lymphedema. Lymphat Res Biol (2009) 0.92
Treatment of post-mastectomy lymphedema with laser therapy: double blind placebo control randomized study. J Surg Res (2010) 0.90
Correlation between bioelectrical spectroscopy and perometry in assessment of upper extremity swelling. Lymphology (2010) 0.90
Prospective evaluation of a prevention protocol for lymphedema following surgery for breast cancer. Lymphology (2009) 0.89
Volumetric evaluation of upper extremities in 250 healthy persons. Clin Physiol Funct Imaging (2007) 0.89
Prevalence and aetiology of lymphoedema after breast cancer treatment in southern Tasmania. Aust N Z J Surg (2000) 0.89
Effect of active resistive exercise on breast cancer-related lymphedema: a randomized controlled trial. Arch Phys Med Rehabil (2010) 0.87
Estimating the probability of lymphedema after breast cancer surgery. Am J Clin Oncol (2011) 0.87
Lymphedema development following breast cancer surgery with full axillary resection. Lymphology (2004) 0.86
Surgical outcomes after breast cancer surgery: measuring acute lymphedema. J Surg Res (2001) 0.85
Disability and health-related quality of life after breast cancer surgery: relation to impairments. South Med J (2010) 0.84
Lymphedema in women with breast cancer: characteristics of patients screened for a randomized trial. Breast Cancer Res Treat (2007) 0.81
Segmental limb volume change as a predictor of the onset of lymphedema in women with early breast cancer. PM R (2011) 0.81
Comparing patients' and clinicians' assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial). Breast Cancer Res Treat (2008) 0.80
Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol (2008) 5.28
Effects of limited work hours on surgical training. J Am Coll Surg (2002) 3.82
Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. J Clin Oncol (2008) 2.72
Accelerated partial breast irradiation with low-dose-rate interstitial implant brachytherapy after wide local excision: 12-year outcomes from a prospective trial. Int J Radiat Oncol Biol Phys (2011) 2.06
Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol (2011) 1.99
Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys (2010) 1.76
Proton therapy for breast cancer after mastectomy: early outcomes of a prospective clinical trial. Int J Radiat Oncol Biol Phys (2013) 1.62
Validation of a web-based predictive nomogram for ipsilateral breast tumor recurrence after breast conserving therapy. J Clin Oncol (2010) 1.59
Risk of lymphedema after regional nodal irradiation with breast conservation therapy. Int J Radiat Oncol Biol Phys (2003) 1.57
Chest wall radiotherapy: middle ground for treatment of patients with one to three positive lymph nodes after mastectomy. Int J Radiat Oncol Biol Phys (2009) 1.55
Staging MR lymphangiography of the axilla for early breast cancer: cost-effectiveness analysis. AJR Am J Roentgenol (2008) 1.42
Utility of DNA repair protein foci for the detection of putative BRCA1 pathway defects in breast cancer biopsies. Mol Cancer Res (2009) 1.37
The feasibility of using natural language processing to extract clinical information from breast pathology reports. J Pathol Inform (2012) 1.30
Standardized method for quantification of developing lymphedema in patients treated for breast cancer. Int J Radiat Oncol Biol Phys (2010) 1.21
Clinical experience with a 3D surface patient setup system for alignment of partial-breast irradiation patients. Int J Radiat Oncol Biol Phys (2006) 1.16
The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions. Breast Cancer Res Treat (2012) 1.15
Accelerated partial-breast irradiation using proton beams: initial clinical experience. Int J Radiat Oncol Biol Phys (2006) 1.13
Breast Cancer Risk Reduction, Version 2.2015. J Natl Compr Canc Netw (2015) 1.12
Comparison of target registration errors for multiple image-guided techniques in accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys (2008) 1.12
Breast cancer diagnosis in women < or = 40 versus 50 to 60 years: increasing size and stage disparity compared with older women over time. Ann Surg Oncol (2006) 1.10
Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy. Int J Radiat Oncol Biol Phys (2011) 1.07
Management of adenoid cystic carcinoma of the breast: a Rare Cancer Network study. Int J Radiat Oncol Biol Phys (2011) 1.07
The association between biological subtype and isolated regional nodal failure after breast-conserving therapy. Int J Radiat Oncol Biol Phys (2010) 1.06
The American Cancer Society guidelines for breast screening with magnetic resonance imaging: an argument for genetic testing. Cancer (2008) 1.05
Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression? Breast Cancer Res Treat (2013) 1.01
Radiotherapy and breast reconstruction: complications and cosmesis with TRAM versus tissue expander/implant. Int J Radiat Oncol Biol Phys (2002) 1.00
Breast cancer after treatment of Hodgkin's lymphoma: risk factors that really matter. Int J Radiat Oncol Biol Phys (2008) 1.00
Use of tamoxifen with postsurgical irradiation may improve survival in estrogen and progesterone receptor-positive male breast cancer. Clin Breast Cancer (2011) 0.99
A voluntary breath-hold treatment technique for the left breast with unfavorable cardiac anatomy using surface imaging. Int J Radiat Oncol Biol Phys (2012) 0.98
Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation. Int J Radiat Oncol Biol Phys (2005) 0.96
Cost comparison of radiation treatment options after lumpectomy for breast cancer. Ann Surg Oncol (2012) 0.94
Lung dose-volume parameters and the risk of pneumonitis for patients treated with accelerated partial-breast irradiation using three-dimensional conformal radiotherapy. J Clin Oncol (2009) 0.92
Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant. Int J Radiat Oncol Biol Phys (2003) 0.92
Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype. Breast Cancer Res Treat (2012) 0.92
Partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer: a cost-effectiveness analysis. Int J Radiat Oncol Biol Phys (2008) 0.91
Diagnosis of breast cancer in women age 40 and younger: delays in diagnosis result from underuse of genetic testing and breast imaging. Am J Surg (2009) 0.91
Increasing eligibility for nipple-sparing mastectomy. Ann Surg Oncol (2013) 0.90
Dosimetric comparison of proton and photon three-dimensional, conformal, external beam accelerated partial breast irradiation techniques. Int J Radiat Oncol Biol Phys (2006) 0.89
External beam accelerated partial-breast irradiation using 32 gy in 8 twice-daily fractions: 5-year results of a prospective study. Int J Radiat Oncol Biol Phys (2012) 0.89
Patterns and risk factors of locoregional recurrence in T1-T2 node negative breast cancer patients treated with mastectomy: implications for postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys (2011) 0.89
Outcome following local-regional recurrence in women with early-stage breast cancer: impact of biologic subtype. Breast J (2015) 0.89
Assessment of patient factors, surgeons, and surgeon teams in immediate implant-based breast reconstruction outcomes. Plast Reconstr Surg (2015) 0.88
Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer. Breast Cancer Res Treat (2013) 0.88
A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important. Am J Surg (2005) 0.88
Lumpectomy cavity shaved margins do not impact re-excision rates in breast cancer patients. Ann Surg Oncol (2011) 0.87
Breast conservation therapy for patients with locally advanced breast cancer. Semin Radiat Oncol (2009) 0.86
Risk of lymphedema after mastectomy: potential benefit of applying ACOSOG Z0011 protocol to mastectomy patients. Breast Cancer Res Treat (2014) 0.86
Tubular carcinoma of the breast: a retrospective analysis and review of the literature. Breast Cancer Res Treat (2005) 0.85
Pathologic response and long-term follow-up in breast cancer patients treated with neoadjuvant chemotherapy: a comparison between classifications and their practical application. Arch Pathol Lab Med (2013) 0.85
Cording following treatment for breast cancer. Breast Cancer Res Treat (2013) 0.85
A pilot study evaluating shaved cavity margins with micro-computed tomography: a novel method for predicting lumpectomy margin status intraoperatively. Breast J (2013) 0.85
Proton radiotherapy for chest wall and regional lymphatic radiation; dose comparisons and treatment delivery. Radiat Oncol (2013) 0.85
Early side effects of three-dimensional conformal external beam accelerated partial breast irradiation to a total dose of 40 Gy in one week (a phase II trial). Int J Radiat Oncol Biol Phys (2010) 0.85
Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer. Int J Radiat Oncol Biol Phys (2005) 0.84
Outcomes of multiple wire localization for larger breast cancers: when can mastectomy be avoided? J Am Coll Surg (2008) 0.84
Breast cancer after treatment of Hodgkin's lymphoma: general review. Int J Radiat Oncol Biol Phys (2008) 0.84
Dosimetric comparison of two different three-dimensional conformal external beam accelerated partial breast irradiation techniques. Int J Radiat Oncol Biol Phys (2006) 0.83
Low local recurrence rate without postmastectomy radiation in node-negative breast cancer patients with tumors 5 cm and larger. Int J Radiat Oncol Biol Phys (2006) 0.83
Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion? Am J Surg (2008) 0.83
Use of preoperative paravertebral block decreases length of stay in patients undergoing mastectomy plus immediate reconstruction. Ann Surg Oncol (2012) 0.82
Lymphedema following treatment for breast cancer: a new approach to an old problem. Crit Rev Oncol Hematol (2013) 0.81
The safety of multiple re-excisions after lumpectomy for breast cancer. Ann Surg Oncol (2011) 0.81
Outcome of multiple-wire localization for larger breast cancers: do multiple wires translate into additional imaging, biopsies, and recurrences? Am J Surg (2009) 0.81
Screening for breast cancer-related lymphedema: the need for standardization. Oncologist (2013) 0.81
The impact of breast cancer-related lymphedema on the ability to perform upper extremity activities of daily living. Breast Cancer Res Treat (2015) 0.81
Intensity modulated proton therapy for postmastectomy radiation of bilateral implant reconstructed breasts: a treatment planning study. Radiother Oncol (2013) 0.81
Sentinel lymph node biopsy at the time of mastectomy does not increase the risk of lymphedema: implications for prophylactic surgery. Breast Cancer Res Treat (2012) 0.80
Risk of local failure in breast cancer patients with lobular carcinoma in situ at the final surgical margins: is re-excision necessary? Int J Radiat Oncol Biol Phys (2013) 0.80
Locoregional recurrence and survival outcomes by type of local therapy and trastuzumab use among women with node-negative, HER2-positive breast cancer. Ann Surg Oncol (2014) 0.80